The role of insulin, insulin-like growth factor-I and growth hormone in counteracting dexamethasone induced nitrogen wasting in rats

Hormone and Metabolic Research

Volumn 29, Issue 1, 1997, Pages 20-24

  Malmlof K ^a,b   Arrhenius Nyberg, V ^a   Saxerholt, H ^a,c   Skottner, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NOVO NORDISK A S   (Denmark)

^c PFIZER INC   (United States)

Author keywords

catabolism; dexamethasone; insulin; nitrogen balance, rat; recombinant human growth hormone; recombinant human insulin like growth factor I

Indexed keywords

DEXAMETHASONE; HUMAN GROWTH HORMONE; INSULIN; NEUTRAL INSULIN; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; MALE; NITROGEN BALANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031058063     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978974     Document Type: Article

References (22)

1. Alberti KGMM, Phil D, Batstone GF, Foster GF, Johnston DG: Relative role of various hormones in mediating the metabolic response to injury. J Parent Ent Nutr 4: 141-146 (1980).
2. Baron J, Huang Z, Orter KE, Bacher JD Jr., Cutler GB: Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263: E489-E492 (1992).
3. Bessey PQ, Lowe KA: Early hormonal changes affect the catabolic response to trauma. Ann Surg 218: 476-491 (1993).
4. Clemmons DR, Underwood LE: Uses of human insulin-like growth factor-I in clinical conditions. J Clin Endocrinol Metab 79: 4-6 (1994).
5. Horber FF, Haymond MW: Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 86: 265-272 (1990).
6. Horber FF, Marsh HM, Haymond MW: Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 40: 141-149 (1991).
7. Kayali AG, Young VR, Goodman AM: Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am J Physiol 252: E621-E626 (1987).
8. Long CHN, Katzin B, Fry EG: The adrenal cortex and carbohydrate metabolism. Endocrinology 26: 309-344 (1949).
9. Luo J, Ried RE, Murphy LJ: Dexamethasone increases hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 127: 1456-1462 (1990).
10. Malmlöf K, Cortova Z, Saxerholt H, Arrhenius-Nyberg V, Karlsson E, Larsson C, Klingström G, Skottner A: IGF-I and GH: metabolic effects during experimentally induced catabolism. In: The insulin-like growth factors and their regulatory proteins. Baxter RC, Gluckman PD, Rosenfeld RG (eds). Excerpta Medica, Amsterdam (1994), 401-408.
11. McCarthy TL, Centrella M, Canalis E: Cortisol inhibits the synthesis of insulin like growth factor-I in skeletal cells. Endocrinology 126: 1569-1575 (1990).
12. McGrath JA, Goldspink DF: Glucocorticoid action on protein synthesis and protein breakdown in isolated skeletal muscles. Biochem J 206: 641-645 (1982).
13. Sapir DG, Pozefsky T, Knochel JP, Walser M: The role of alanine and glutamine in steroid-induced nitrogen wasting in man. Clin Sci Mol Med 53: 215-220 (1977).
14. SAS Institute Inc.: SAS user's guide, statistics, 5th ed. SAS Institute Inc., Cary, NC (1985).
15. Shimizu K, Amagaya S, Ogihara Y: Analysis of corticosterone in the serum of mice and rats, using high performance liquid chromatography. J Chromatogr 272: 170-175 (1983).
16. Simmons PS, Miles JE, Haymond MW: Increased proteolysis: an effect of increases in plasma cortisol within the physiological range. J Clin Invest 73: 412-420 (1984).
17. Skottner A, Clark RG, Fryklund L, Robinson ICAF: Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin like growth factor-I. Endocrinology 124: 2519-2526 (1989).
18. Smith R, Williamson RH: Biochemical effects of human injury. Trends Biochem Sci 8: 142-146 (1983).
19. Tomas FM, Knowels SE, Owens PC, Chandler CS, Francis GL, Read LC, Ballard: Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J 282: 91-97 (1992).
20. Trainer PJ, Kirk JMW, Savage MO, Grossman AB, Besser GM: Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone. J Endocrinol 134: 513-517 (1992).
21. Woolfson AMJ, Heatley RV, Allison SP: Insulin to inhibit protein catabolism after injury. N Engl J Med 300: 14-17 (1979).
22. Ørtoft G, Kelly C, Briiel A-M, Smith A, Carter N, Oxlund H: Glucocorticoids inhibit the growth hormone induced increase in serum IGF-I and its mRNA, body weight and muscle mass of rats. EurJ Exp Musculoskel Res 2: 135-142 (1993).